Vol 13, No 10 (October 31, 2024) - Translational Lung Cancer Research

Expert Consensus

Systems mapping: a novel approach to national lung cancer screening implementation in Australia

Sandra Marjanovic, Andrew Page, Emily Stone, Danielle J. Currie, Nicole M. Rankin, Renelle Myers, Fraser Brims, Neal Navani, Kate A. McBride

Translational Lung Cancer Research

2024;

(10)

:2466-2478

(31 October 2024)

PDF Full Text (2737) Peer Review File COI Form Open Access

Original Article

Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis

Baishen Zhang, Jing Chen, Hui Yu, Meichen Li, Likun Chen

Translational Lung Cancer Research

2024;

(10)

:2479-2490

(31 October 2024)

PDF Full Text (1226) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review

Izabela Chmielewska, Paweł Krawczyk, Magdalena Wójcik-Superczyńska, Anna Grenda, Michał Gil, Katarzyna Stencel, Robert Kieszko, Tomasz Jankowski, Janusz Milanowski

Translational Lung Cancer Research

2024;

(10)

:2491-2499

(31 October 2024)

PDF Full Text (1679) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy and safety of radial probe endobronchial ultrasound-guided biopsy for peripheral lung lesions in chronic obstructive pulmonary disease patients

Young Seok Lee, Kyung Soo Hong, Jong Geol Jang, June Hong Ahn

Translational Lung Cancer Research

2024;

(10)

:2500-2510

(31 October 2024)

PDF Full Text (1025) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer

Youngjoo Lee, Seog-Yun Park, Geon Kook Lee, Hyun-Ju Lim, Yu-Ra Choi, Jaemin Kim, Ji-Youn Han

Translational Lung Cancer Research

2024;

(10)

:2511-2523

(31 October 2024)

PDF Full Text (1494) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Exposure-lag response of surface net solar radiation on lung cancer incidence: a global time-series analysis

Xuanzhuang Lu, Runchen Wang, Jianfu Li, Shixuan Lyu, Jianrong Zhang, Qixia Wang, Wenhao Chi, Ran Zhong, Chao Chen, Xinjian Wu, Ruiyu Hu, Zhixuan You, Yuqi Mai, Songlin Xie, Jiayu Lin, Boyu Zheng, Qiu Zhong, Jianxing He, Wenhua Liang

Translational Lung Cancer Research

2024;

(10)

:2524-2537

(31 October 2024)

PDF Full Text (1865) Reporting Checklist Peer Review File COI Form Open Access

Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired BRAF V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer patients

Cheng-Di Weng, Ke-Jun Liu, Shi Jin, Jun-Wei Su, Yi-Hui Yao, Cheng-Zhi Zhou, Yu-Fa Li, Ze-Xin Chen, Hua-Jun Chen, Yan-Ying Li, Ke-Jing Tang, Jin-Ji Yang

Translational Lung Cancer Research

2024;

(10)

:2538-2548

(31 October 2024)

PDF Full Text (2648) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients

Quan Zheng, Jian Zhou, Yuanjin Zhang, Tengyong Wang, Dongsheng Wu, Qiang Pu, Jiandong Mei, Hu Liao, Lunxu Liu

Translational Lung Cancer Research

2024;

(10)

:2549-2560

(31 October 2024)

PDF Full Text (1377) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Electromagnetic navigation bronchoscopy-guided preoperative lung nodule localization in video-assisted thoracic surgery (VATS): a learning curve analysis

Menghua Xue, Ke Lan, Xiaolong Yan, Tao Jiang, Xiaoping Wang, Feng Tian, Yunfeng Ni, Jinbo Zhao

Translational Lung Cancer Research

2024;

(10)

:2561-2572

(31 October 2024)

PDF Full Text (710) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Impact of docetaxel plus ramucirumab therapy on interstitial lung disease in recurrent advanced non-small cell lung cancer patients

Noriyuki Ebi, Hiroyuki Inoue, Yuta Fujimoto, Maiya Chen, Rei Sanai, Natsumi Kushima, Yusuke Osaki, Takato Ikeda, Akira Nakao, Yuki Shundo, Toyoshi Yanagihara, Naoki Hamada, Masaki Fujita

Translational Lung Cancer Research

2024;

(10)

:2573-2584

(31 October 2024)

PDF Full Text (1288) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Predicting prognosis in patients with stage IA lung adenocarcinoma with a micropapillary component using a nomogram based on computed tomography radiomics and clinicopathologic factors: a retrospective analysis

Ying Li, Junfeng Zhao, Ruyue Li, Xiujing Yao, Xue Dong, Ying Zhao, Zhongshuo Xia, Yali Xu, Yintao Li

Translational Lung Cancer Research

2024;

(10)

:2585-2602

(31 October 2024)

PDF Full Text (1324) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic significance of bone metastasis and clinical value of bone radiotherapy in metastatic non-small cell lung cancer receiving PD-1/PD-L1 inhibitors: results from a multicenter, prospective, observational study

Huiling Dong, Aihua Lan, Jie Gao, Yulin An, Li Chu, Xi Yang, Xiao Chu, Jie Hu, Qian Chu, Jianjiao Ni, Zhengfei Zhu

Translational Lung Cancer Research

2024;

(10)

:2603-2616

(31 October 2024)

PDF Full Text (1530) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A nomogram for predicting invasiveness of lung adenocarcinoma manifesting as ground-glass nodules based on follow-up CT imaging

Hanting Li, Qinyue Luo, Yuting Zheng, Chengyu Ding, Jinrong Yang, Leqing Chen, Xiaoqing Liu, Tingting Guo, Jun Fan, Xiaoyu Han, Heshui Shi

Translational Lung Cancer Research

2024;

(10)

:2617-2635

(31 October 2024)

PDF Full Text (914) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Inflammation, tertiary lymphoid structures, and lung cancer: a bibliometric analysis

Xiwen Liu, Huiting Liu, Linchong Huang, Lixuan Lin, Qi Cai, Yang Xiang, Zengfu Liu, Shuxin Zeng, Jianxing He, Wenhua Liang

Translational Lung Cancer Research

2024;

(10)

:2636-2648

(31 October 2024)

PDF Full Text (1388) Peer Review File COI Form Open Access

Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50%

Alejandro Olivares-Hernández, Luis Posado-Domínguez, Juan Carlos Redondo-González, Laura Corvo-Félix, Lorena Bellido Hernández, Emilio Fonseca-Sánchez, Edel del Barco-Morillo

Translational Lung Cancer Research

2024;

(10)

:2649-2659

(31 October 2024)

PDF Full Text (1599) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

SWItch/Sucrose Nonfermentable complex-deficient pulmonary neoplasms: clinicopathologic characteristics and outcomes to radiotherapy and immunotherapy

Yu Gu, Songtao Lai, Juan Yang, Junhua Zhang, Xingwen Fan, Qiang Zheng

Translational Lung Cancer Research

2024;

(10)

:2660-2672

(31 October 2024)

PDF Full Text (1482) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)

Shinnosuke Takemoto, Minoru Fukuda, Ryosuke Ogata, Hiroaki Senju, Nanae Sugasaki, Katsumi Nakatomi, Hiromi Tomono, Takayuki Suyama, Eisuke Sasaki, Midori Matsuo, Kazumasa Akagi, Fumiko Hayashi, Yosuke Dotsu, Sawana Ono, Noritaka Honda, Hirokazu Taniguchi, Hiroshi Gyotoku, Takaya Ikeda, Seiji Nagashima, Hiroshi Soda, Akitoshi Kinoshita, Hiroshi Mukae

Translational Lung Cancer Research

2024;

(10)

:2673-2682

(31 October 2024)

PDF Full Text (1444) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Microbiota modulate immune repertories in lung adenocarcinoma via microbiota-immunity interactive network

Peng Liang, Qianxi Chen, Xiaoping Chen, Xiaolin Zhang, Yizhen Xiao, Guangni Liang, Ming Liu, Jianxing He, Wenhua Liang, Yufeng Liang, Bo Chen

Translational Lung Cancer Research

2024;

(10)

:2683-2697

(31 October 2024)

PDF Full Text (1539) Reporting Checklist Peer Review File COI Form Open Access

Construction of a lung cancer 3D culture model based on alginate/gelatin micro-beads for drug evaluation

Ziying Zhao, Xiaoqing Feng, Huijuan Wu, Shuisheng Chen, Changsong Ma, Ziyun Guan, Luwen Lei, Kejing Tang, Xiao Chen, Yong Dong, Yubo Tang

Translational Lung Cancer Research

2024;

(10)

:2698-2712

(31 October 2024)

PDF Full Text (1738) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Necroptosis-related lncRNAs: biomarkers for predicting prognosis and immune response in lung adenocarcinoma

Chunxuan Lin, Kunpeng Lin, Xiaochun Lin, Hai Yuan, Yingying Zhang, Zhijun Xie, Yong Dai, Luhao Liu, Yoshihisa Shimada, Taichiro Goto, Katsuhiro Okuda, Taisheng Liu, Chenggong Wei

Translational Lung Cancer Research

2024;

(10)

:2713-2728

(31 October 2024)

PDF Full Text (1303) Reporting Checklist Peer Review File COI Form Open Access

Role of CENPL, DARS2, and PAICS in determining the prognosis of patients with lung adenocarcinoma

Rongjian Xu, Fengyi Han, Yandong Zhao, Ao Liu, Ning An, Baogang Wang, Patrick Zardo, José Sanz-Santos, Aimée J. P. M. Franssen, Erik R. de Loos, Min Zhao

Translational Lung Cancer Research

2024;

(10)

:2729-2745

(31 October 2024)

PDF Full Text (1796) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

DeepGR: a deep-learning prognostic model based on glycolytic radiomics for non-small cell lung cancer

Tingting Fu, Peipei Yan, Lina Zhou, Zhihua Lu, Ao Liu, Xiao Ding, Jacopo Vannucci, Paul Hofman, Andrzej Swierniak, Edyta Szurowska, Junjun Zhang, Shicheng Li

Translational Lung Cancer Research

2024;

(10)

:2746-2760

(31 October 2024)

PDF Full Text (1468) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort study

Shuai-Dong Lin, Chang-Yong Tong, Dan-Dong Huang, Antonio Rossi, Hiroyuki Adachi, Miao Miao, Wen-Xin Zheng, Jing Guo

Translational Lung Cancer Research

2024;

(10)

:2761-2772

(31 October 2024)

PDF Full Text (1657) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Blood biomarkers to predict the efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer patients

Yang Pan, Xuanhong Jin, Jiandong Hong, Yuxia Wang, Haoting Xu, Jingwei Lin, Yan Zhang, Kailai Yin, Jinhao Zhang, Kentaro Inamura, Dujiang Liu, Feng Li, Jian Zeng

Translational Lung Cancer Research

2024;

(10)

:2773-2786

(31 October 2024)

PDF Full Text (1893) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study

Wei-Hong Zhang, Bing-Xue Li, Chen-Xi Ma, Jian Wang, Fan Yang, Yan-Juan Xiong, Shu-Zhan Li, Jia-Li Zhang, Wei-Jiao Du, Zhen-Zhen Hui, Meng Shen, Li Zhou, Run-Mei Li, Xiao Tian, Ying Han, Bao-Zhu Ren, Yoshinobu Ichiki, Sang Chul Lee, Xin-Wei Zhang, Shui Cao, Xiu-Bao Ren, Liang Liu

Translational Lung Cancer Research

2024;

(10)

:2787-2801

(31 October 2024)

PDF Full Text (2073) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Clinical, pathological, and computed tomography morphological features of lung cancer with spread through air spaces

Xiuming Zhang, Wei Qiao, Jiannan Shen, Qianlai Jiang, Chunhan Pan, Yunnong Wang, Joanna Bidzińska, Feng Dai, Lei Zhang

Translational Lung Cancer Research

2024;

(10)

:2802-2812

(31 October 2024)

PDF Full Text (1300) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

What do we know about the role of neoadjuvant targeted therapy in early-stage EGFR-mutant and ALK-fused non-small cell lung cancer?—a narrative review of the current literature

Marcel Kemper, Sandra Elges, Peter Kies, Karsten Wiebe, Georg Lenz, Annalen Bleckmann, Georg Evers

Translational Lung Cancer Research

2024;

(10)

:2813-2827

(31 October 2024)

PDF Full Text (2292) Reporting Checklist Peer Review File COI Form Open Access

Study Protocol

TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial

Baiqiang Dong, Long Chen, Qingsong Pang, Ou Jiang, Hong Ge, Yufeng Cheng, Rongrong Zhou, Xiangjiao Meng, Jie Li, Xuan Zhu, Xunqiang Wang, Qiuyue Cao, Yongling Ji, Ming Chen

Translational Lung Cancer Research

2024;

(10)

:2828-2837

(31 October 2024)

PDF Full Text (1692) Reporting Checklist Peer Review File COI Form Open Access

Navigation of video-assisted thoracoscopic surgery using electromagnetic versus CT-guided localization (NOVEL): a study protocol for comparing procedural success and complication rates in a prospective, multicenter, randomized controlled, non-inferiority phase III trial

Juntao Xie, Dingpei Han, Yang Zhou, Boxuan Huang, Can Ge, Agathe Seguin-Givelet, Ajay Wagh, Yeon Wook Kim, Weicheng Kong, Censong Xu, Hecheng Li, Jie Zhang; the NOVEL study group

Translational Lung Cancer Research

2024;

(10)

:2838-2846

(31 October 2024)

PDF Full Text (886) Reporting Checklist Peer Review File COI Form Open Access